^
Association details:
| Biomarker: | PIK3CA E545K |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | lapatinib (EGFR inhibitor, HER2 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
PI3K Hyperactivation Results in Lapatinib Resistance that is Reversed by the mTOR/PI3K Inhibitor NVP-BEZ235
Excerpt:
...we have identified that the two most prevalent breast cancer mutations in PIK3CA (E545K and H1047R) also confer resistance to lapatinib.
DOI:
10.1158/0008-5472.CAN-08-1740
